70 related articles for article (PubMed ID: 17383509)
1. Primary and adjunctive uses of botulinum toxin type A in the periorbital region.
Balikian RV; Zimbler MS
Otolaryngol Clin North Am; 2007 Apr; 40(2):291-303. PubMed ID: 17383509
[TBL] [Abstract][Full Text] [Related]
2. Primary and adjunctive uses of botulinum toxin type A in the periorbital region.
Balikian RV; Zimbler MS
Facial Plast Surg Clin North Am; 2005 Nov; 13(4):583-90, vii. PubMed ID: 16253845
[TBL] [Abstract][Full Text] [Related]
3. A pilot study on the effect of epinephrine on botulinum toxin treatment for periorbital rhytides.
Hantash BM; Gladstone HB
Dermatol Surg; 2007 Apr; 33(4):461-8. PubMed ID: 17430381
[TBL] [Abstract][Full Text] [Related]
4. Dermal and epidermal remodeling using botulinum toxin type A for facial, non reducible, hyperkinetic lines: two case studies.
Bowler PJ
J Cosmet Dermatol; 2008 Sep; 7(3):241-4. PubMed ID: 18789065
[TBL] [Abstract][Full Text] [Related]
5. Update on perioral cosmetic enhancement.
Suryadevara AC
Curr Opin Otolaryngol Head Neck Surg; 2008 Aug; 16(4):347-51. PubMed ID: 18626254
[TBL] [Abstract][Full Text] [Related]
6. Anterior chemodenervation of levator palpebrae superioris with botulinum toxin type-A (Botox) to induce temporary ptosis for corneal protection.
Naik MN; Gangopadhyay N; Fernandes M; Murthy R; Honavar SG
Eye (Lond); 2008 Sep; 22(9):1132-6. PubMed ID: 17510652
[TBL] [Abstract][Full Text] [Related]
7. Eyebrow asymmetry: definition and symmetrical correction using botulinum toxin A.
Tiryaki T; Ciloglu NS
Aesthet Surg J; 2007; 27(5):513-7. PubMed ID: 19341680
[TBL] [Abstract][Full Text] [Related]
8. Complications in fillers and Botox.
Niamtu J
Oral Maxillofac Surg Clin North Am; 2009 Feb; 21(1):13-21, v. PubMed ID: 19185791
[TBL] [Abstract][Full Text] [Related]
9. Clostridium botulinum type A toxin for the treatment of upper face animation lines: an Iranian experience.
Farahvash MR; Arad S
J Cosmet Dermatol; 2007 Sep; 6(3):152-8. PubMed ID: 17760691
[TBL] [Abstract][Full Text] [Related]
10. Balanced botox chemodenervation of the upper face: symmetry in motion.
Olson JJ
Semin Plast Surg; 2007 Feb; 21(1):47-53. PubMed ID: 20567657
[TBL] [Abstract][Full Text] [Related]
11. Patient-reported outcomes with botulinum neurotoxin type A.
Carruthers A; Carruthers J
J Cosmet Laser Ther; 2007; 9 Suppl 1():32-7. PubMed ID: 17885884
[TBL] [Abstract][Full Text] [Related]
12. [Botulinum toxin A in the treatment of the wrinkles in the upper third of the face].
Gassia V
Ann Dermatol Venereol; 2008 Feb; 135 Suppl 3():S175-80. PubMed ID: 18342124
[TBL] [Abstract][Full Text] [Related]
13. The use of botulinum toxin A in perioral rejuvenation.
Kaplan SE; Sherris DA; Gassner HG; Friedman O
Facial Plast Surg Clin North Am; 2007 Nov; 15(4):415-21, v-vi. PubMed ID: 18005882
[TBL] [Abstract][Full Text] [Related]
14. Effectivity of Dysport in patients with blepharospasm and hemifacial spasm who experienced failure with Botox.
Badarny S; Susel Z; Honigman S
Isr Med Assoc J; 2008 Jul; 10(7):520-2. PubMed ID: 18751631
[TBL] [Abstract][Full Text] [Related]
15. Treatment for multiple periorbital eccrine hidrocystomas: botulinum toxin A.
Woolery-Lloyd H; Rajpara V; Nijhawan RI
J Drugs Dermatol; 2009 Jan; 8(1):71-3. PubMed ID: 19180900
[TBL] [Abstract][Full Text] [Related]
16. Botulinum neurotoxins: fundamentals for the facial plastic surgeon.
Adelson RT
Am J Otolaryngol; 2007; 28(4):260-6. PubMed ID: 17606044
[TBL] [Abstract][Full Text] [Related]
17. Equipotent concentrations of Botox and Dysport in the treatment of palmar hyperhidrosis.
Rystedt A; Swartling C; Färnstrand C; Naver H
Acta Derm Venereol; 2008; 88(5):458-61. PubMed ID: 18779882
[TBL] [Abstract][Full Text] [Related]
18. Core curriculum for plastic surgical nursing: botulinum toxin type A for facial aesthetics.
Weber BB
Plast Surg Nurs; 2008; 28(3):136-41. PubMed ID: 18794738
[No Abstract] [Full Text] [Related]
19. Advanced botulinum toxin techniques against wrinkles in the upper face.
Salti G; Ghersetich I
Clin Dermatol; 2008; 26(2):182-91. PubMed ID: 18472059
[TBL] [Abstract][Full Text] [Related]
20. Comparing two types of botulinum-A toxin detrusor injections in patients with severe neurogenic detrusor overactivity: a case-control study.
Grosse J; Kramer G; Jakse G
BJU Int; 2009 Sep; 104(5):651-6. PubMed ID: 19281462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
